The Risky Business of Embryo Selection
By Julianna LeMieux,
Genetic Engineering & Biotechnology News
| 04. 01. 2019
An anonymous incubator space just off the New Jersey Turnpike is the unlikely setting for Genomic Prediction, a genetic testing start-up that is daring to push the boundaries of preimplantation embryo screening, a technique curiously bereft of regulatory oversight. The company’s co-founder and chief scientific officer, Washington State native Nathan Treff, PhD, occupies a small office decorated with Pearl Jam posters, a Seattle Seahawks helmet, and a framed Genomic Prediction logo that features a sigil clearly inspired by the “Game of Thrones” House of Stark.
The lab space is well equipped with some Illumina benchtop sequencers and robotic devices, but there’s nothing to suggest the trail blazing path Genomic Prediction is pursuing. In addition to standard genetic tests—chromosome counts for Down syndrome and other aneuploidies and mutational tests for rare monogenic disorders—the Genomic Prediction menu includes newly developed polygenic risk scores (PRS) which assess the likelihood of developing complex polygenic diseases such as type 1 and 2 diabetes, coronary artery disease, cancer, hypothyroidism, inflammatory bowel disease, schizophrenia and others. Indeed, the company just secured its first formal client for the... see more
Related Articles
By Fiona Harvey, The Guardian | 01.06.2021
By Jeffrey Mervis, Science | 01.06.2021
Low-income commuters who rely on public transit face many challenges—multiple transfers, long waits, and off-hour travel—that aren’t measured in the usual ridership surveys. Vanessa Frias-Martinez, a computer scientist at the University of Maryland, College Park, wants to ease their commute...
By Sharon Begley, STAT | 01.06.2021
Biologists tend not to discuss experimental results on a handful of cells and a single solitary mouse — too preliminary, too sketchy. David Liu of the Broad Institute therefore had no plans to present such findings, which he’d peeked at...
By Gwen D’Arcangelis, Guest Contributor
| 01.07.2021
Photo by Adrian Lange on Unsplash
Living under the COVID-19 pandemic has justifiably created fear and uncertainty about germs and their evolving contagiousness and lethality. Against the backdrop of the natural evolution of the coronavirus and emerging new strains, many ruminate over further alarming scenarios—from questions about the coronavirus’s possible lab origins, to worry over the possibility of biohackers engineering new pandemic germs. New gene editing technologies like CRISPR make these scenarios all the more frightening, as they...